Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00114959
Status:
TERMINATED
Last Update Posted:
2015-01-15
First Post:
2005-06-20
Brief Title:
Homoharringtonine With Oral Gleevec in Chronic Accelerated and Blast Phase Chronic Myeloid Leukemia CML
Sponsor:
Organization:
Teva Branded Pharmaceutical Products RD Inc